Medical Devices industry M&A deals total $1bn globally in May 2022

Total Medical devices industry M&A deals worth $1bn were announced globally in May 2022, led by ConMed’s $255m acquisition of In2Bones Global, according to GlobalData’s deals database.

The value marked a decrease of 32% over the previous month of $1.47bn and a drop of 86.6% when compared with the last 12-month average, which stood at $7.47bn.

Comparing M&A deals value in different regions of the globe, Asia-Pacific held the top position, with total announced deals in the period worth $554.65m. At the country level, the US topped the list in terms of deal value at $265m.

In terms of volumes, North America emerged as the top region for Medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in May 2022 was the US with 16 deals, followed by the Sweden with three and Canada with three.

In 2022, as of May, Medical devices M&A deals worth $9.75bn were announced globally, marking an increase of 72.1% year on year.

Medical devices industry M&A deals in May 2022: Top deals

The top five M&A deals accounted for 82.2% of the overall value during May 2022.

The combined value of the top five Medical devices M&A deals stood at $825.74m, against the overall value of $1bn recorded for the month.

The top five Medical devices industry M&A deals of May 2022 tracked by GlobalData were:

1) ConMed $255m acquisition deal with In2Bones Global

2) The $227.93m acquisition of 57.5% stake in Allm by DeNA

3) Straumann $138.06m acquisition deal with SunshineSmile

4) The $108.2m acquisition of Zhejiang Longterm Medical Technology by Winner Medical Group

5) Winner Medical Group $96.54m acquisition deal for 65.55% stake with Hunan Pingan Medical Device Technology